U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...

UT Southwestern Medical Center announced it received a five-year federal grant from the Advanced Research Projects Agency for ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...

Researchers are developing functional, patient-specific livers using 3D bioprinting and stem cell technology to eliminate the ...

Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead increase the risk of chronic liver damage and cancer as we age.

The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. Silymarin in milk thistle may ...